Cost control invariably interacts with issues of quality and health care access and thus this volume deals not simply with costs but, more importantly, with value. Both macro and micro concerns are covered, including health care reforms, the implementation and effects of policy prescriptions and the economic evaluation of new drugs and technologies.
nl
en
